Home › Pulmonary Hypertension › Oklahoma
Pulmonary Hypertension clinical trials in Oklahoma
4 studies for Pulmonary Hypertension are looking for participants at sites in Oklahoma.
Cities in Oklahoma
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Oklahoma, Oklahoma City
Recruiting
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- The University of Oklahoma Health Sciences Center, Oklahoma City
- Oklahoma Heart Institute, Tulsa
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Oklahoma Heart Institute, Tulsa
Recruiting
Ages 18 to 85 · All sexes · Updated Aug 18, 2026 · NCT07214376Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Integris Baptist Medical Center, Oklahoma City
- Oklahoma Heart Institute at Utica, Tulsa
- Saint Francis Hospital, Tulsa
Recruiting
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06526195From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.